|
|
|
|
|
|||
NOR 2019
COI 0.66 %
Breed relevant health information:
Elbows
normal
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
|
||
NOR 2014
COI 1.42 %
*
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
|||
NOR 2021
COI 0.36 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
NOR 2017
COI 2.02 %
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
|
|
|||
NOR 2017
COI 2.01 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
||
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Søsveens Helmi
|
2 May 2021 | |||||||||
Hoito’s Cava
|
29 Jul 2021 | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | ||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Siblings | ||||||||||
Hoito’s Ikaros
|
13 Jan 2024 | |||||||||
Hoito’s Ilona
|
13 Jan 2024 | |||||||||
Hoito’s Ipa
|
13 Jan 2024 | |||||||||
Hoito’s Issko
|
13 Jan 2024 | |||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
Offspring |